CIK 0000109657
- Non-accelerated filer
- Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 941620407
- Phone
- +1 800-304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- 4 Grant or award Exec. Chair. and Interim CEO acquired 278,058 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO & Secretary acquired 100,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 278,058 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Conversion Director acquired 50,102 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,083 shares at an average $5.17 ($26,299)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Former Officer and Director sold 183,700 shares at an average $0.34 ($62,837)
- 4 Open-market sale Former Officer and Director sold 200,000 shares at an average $0.30 ($60,500)
Page 2 of 8 · 160 filings